Cargando…
Untargeted metabolomics for profiling oncogene-specific metabolic signatures of prostate cancer
Oncogene-associated metabolic signatures in prostate cancer, identified by an integrative analysis of cultured cells and murine and human tumors, suggest that AKT activation results in a glycolytic phenotype whereas MYC induces aberrant lipid metabolism. Heterogeneity in human tumors makes this simp...
Autores principales: | Priolo, Carmen, Loda, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905328/ https://www.ncbi.nlm.nih.gov/pubmed/27308491 http://dx.doi.org/10.1080/23723556.2014.1001197 |
Ejemplares similares
-
When fat goes down, prostate cancer is on the ropes
por: Zadra, Giorgia, et al.
Publicado: (2019) -
Approaching untargetable tumor-associated antigens with antibodies
por: Dao, Tao, et al.
Publicado: (2013) -
Oncogenic regulatory circuits driven by 19q13 rs11672691 underlies prostate cancer aggressiveness
por: Xia, Ji-Han, et al.
Publicado: (2018) -
ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer
por: Mishra, Prachi, et al.
Publicado: (2018) -
Oncogenic long noncoding RNA FAL1 in human cancer
por: Zhong, Xiaomin, et al.
Publicado: (2015)